Collegium Pharma (COLL) Misses Q4 EPS by $1.77
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Collegium Reports Fourth Quarter and Full-Year 2021 Financial Results
February 24, 2022 4:01 PM ESTBDSI Acquisition Expected to Close Late Q1 2022
2022 Revenue Guidance of $315-$330 Million, Growth Driven by Xtampza ER
Full-Year Net Income of $71.5 Million and Full-Year Adjusted EBITDA of $118.3 million
Cash Balance of $186.4 Million
Conference Call Scheduled for Today at 4:30 p.m. ET
STOUGHTON, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc.... More
